SALOMONE, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 5.922
EU - Europa 2.949
AS - Asia 2.006
AF - Africa 325
SA - Sud America 304
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.523
Nazione #
US - Stati Uniti d'America 5.688
SG - Singapore 1.116
IT - Italia 929
IE - Irlanda 721
CN - Cina 690
UA - Ucraina 610
BR - Brasile 279
CA - Canada 221
RU - Federazione Russa 195
CI - Costa d'Avorio 167
DE - Germania 154
SN - Senegal 127
SE - Svezia 97
VN - Vietnam 76
FR - Francia 43
GB - Regno Unito 39
IN - India 32
FI - Finlandia 26
BE - Belgio 21
NL - Olanda 20
CH - Svizzera 18
GR - Grecia 14
IR - Iran 12
UZ - Uzbekistan 12
AT - Austria 11
TR - Turchia 10
AU - Australia 9
CZ - Repubblica Ceca 8
ES - Italia 8
ZA - Sudafrica 8
AR - Argentina 7
CO - Colombia 7
EU - Europa 7
IQ - Iraq 7
LB - Libano 7
MA - Marocco 7
EC - Ecuador 6
JP - Giappone 6
MX - Messico 6
PK - Pakistan 6
BD - Bangladesh 5
BG - Bulgaria 5
EG - Egitto 5
HK - Hong Kong 5
HR - Croazia 5
PL - Polonia 5
AZ - Azerbaigian 4
IL - Israele 4
NG - Nigeria 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
RS - Serbia 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PY - Paraguay 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
ID - Indonesia 1
IM - Isola di Man 1
KE - Kenya 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 11.523
Città #
Santa Clara 999
Chandler 916
Dublin 721
Jacksonville 686
Singapore 632
Boardman 325
Chicago 315
Catania 274
Cambridge 200
Lawrence 198
Andover 195
Nanjing 180
Toronto 169
Abidjan 167
Houston 163
Ashburn 127
Dakar 127
Wilmington 110
Des Moines 87
Civitanova Marche 83
San Mateo 83
Dong Ket 65
Shenyang 63
Nanchang 62
Grafing 53
Council Bluffs 51
Hebei 51
Ottawa 48
Bremen 46
Saint Petersburg 45
Messina 39
Changsha 38
Jiaxing 35
Beijing 34
Tianjin 30
Falls Church 27
Dearborn 22
Los Angeles 22
Helsinki 21
Palermo 21
Norwalk 19
Seattle 19
São Paulo 19
Rome 18
Florence 17
Milan 17
Redwood City 17
Jinan 16
Lissone 15
Moscow 15
Brussels 14
Munich 14
Pune 14
Hangzhou 13
Curitiba 12
Guangzhou 12
Kunming 12
Liberty Lake 12
Washington 12
Irvine 11
Hanoi 10
Ningbo 10
Padova 10
Tappahannock 10
Campobasso 9
Rio de Janeiro 9
Sesto Fiorentino 9
The Dalles 9
Belo Horizonte 8
Vicenza 8
Amsterdam 7
Den Haag 7
Kraainem 7
Turin 7
Caltanissetta 6
Frankfurt Am Main 6
Shanghai 6
Aci Catena 5
Baghdad 5
Paternò 5
Phoenix 5
Abuja 4
Baku 4
Bangalore 4
Bogotá 4
Canton 4
Catanzaro 4
Civitavecchia 4
Contagem 4
Foggia 4
Goiânia 4
Hyderabad 4
Lahore 4
Lanzhou 4
Manaus 4
Maruggio 4
Mascalucia 4
Paterno 4
Providence 4
Siracusa 4
Totale 8.062
Nome #
Current drug treatments targeting dopamine D3 receptor 167
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 163
Dopaminergic-GABAergic interplay and alcohol binge drinking 153
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 122
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 119
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 115
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 111
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 108
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 104
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats 99
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 99
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 98
Epigenetic drugs for Alzheimer's disease: hopes and challenges 92
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 92
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 91
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 87
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 86
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 85
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 85
Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders 84
Isoflavones: estrogenic activity, biological effect and bioavailability 84
P2X7 receptor antagonism: implications in diabetic retinopathy 82
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 82
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 82
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 82
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome 81
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 81
Particle identification with the 4 pi CHIMERA detector array 78
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 78
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 78
Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy 77
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 75
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 75
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System 75
Activity of dihydrothienopyridine S312 enantiomers on L-type calcium channels in isolated rat aorta and cerebral microvessels 74
Effects of phenformin on the proliferation of human tumor cell lines 74
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice 74
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 73
Pleiotropic effects of glitazones: a double edge sword? 72
Clinical course of N-methyl-D-aspartate receptor encephalitis and the effectiveness of cyclophosphamide treatment 72
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 72
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 72
Controversies in Glaucoma: Current Medical Treatment and Drug Development 71
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 70
A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin 70
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 70
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 70
PLGA-PEG NANOPARTICLES LOADED WITH ANTIPSYCHOTIC AGENTS: INFLUENCE OF DRUG MOLECULES ON THE CRYOPROTECTIVE EFFECT OF SUCROSE. 69
Dopamine, cognitive impairments and second-generation antipsychotics: From mechanistic advances to more personalized treatments 69
Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery 68
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 68
Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis 68
Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson’s disease from atypical Parkinsonian syndromes 67
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 67
Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1 65
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 65
Abnormal vascular responses and cerebral reperfusion injury in ApoE-deficient mice on Western diet 65
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 65
Forehead Tremor: A Clinical Presentation of Myasthenia Gravis? 65
INHIBITION BY BOSENTAN, AN ENDOTHELIN ANTAGONIST, OF THE HYPERSENSITIVITY TO CA2+ CHANNEL ACTIVATOR EVOKED BY SALT-LOADING IN BASILAR ARTERY OF STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS 65
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 64
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 64
Retinal protection and distribution of curcumin in vitro and in vivo 64
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 63
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 63
Preliminary pharmacokinetic and clinical evaluation of ofloxacin in dental and oral cavity diseases 62
Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011 62
Lipoprotein(a) serum levels in diabetic patients with retinopathy 62
Exogenous nitric oxide mediates changes of vascular contractility induced by activated glia 62
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 62
A THERAPEUTIC DOSAGE OF AMLODIPINE PREVENTS VASCULAR HYPOREACTIVITY INDUCED IN RATS BY LIPOPOLYSACCHARIDE 62
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 62
CALCIUM ANTAGONISTS AND ENDOTHELIAL FUNCTION: FOCUS ON NITRIC OXIDE AND ENDOTHELIN 61
Migraine: an overview 61
eNOS phosphorylation modulates vascular reactivity and stroke outcome in S1179D and S1179A knock-in mice 61
Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis 61
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 61
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 60
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors 60
Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery 60
Cistus incanus and Cistus monspeliensis inhibit the contractile response in isolated rat smooth muscle 60
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools 60
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium 60
Inhibition of cerebral vasoconstriction by dantrolene and nimodipine 59
Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells 59
Role of nitric oxide in the contractile response to 5-hydroxytryptamine of the basilar artery from Wistar Kyoto and stroke-prone rats 59
Clinical pharmacology of novel anti-Alzheimer disease modifying medications. 59
Flavopiridol, an inhibitor of cyclin-dependent kinase 4, reverses cognitive deficits induced by β-amyloid peptide 1–42 59
Farmaci della coaugulazione 58
Ocular allergy 58
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 58
Centenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems 57
Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats 57
Functional interaction of Lacidipine with calcium channels in vascular smooth muscle 57
Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine 57
Analytical and experimental pharmacology, challenges ahead 57
Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats 57
Evaluation of Neostigmine responsiveness with concentric-needle single fiber electromyography in myasthenia gravis: A comparative study 57
Drugs that reverse chloroquine resistance in malaria 57
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside 56
Totale 7.468
Categoria #
all - tutte 44.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.457


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 0 0 0 0 0 0 0 125 53
2020/20211.288 21 99 147 5 300 52 185 10 152 27 160 130
2021/20221.549 198 211 28 25 227 53 217 57 148 8 59 318
2022/20232.734 232 124 40 279 277 463 30 511 621 15 88 54
2023/2024992 60 149 54 73 36 208 17 62 8 17 187 121
2024/20253.494 51 626 214 248 911 464 115 174 297 389 5 0
Totale 11.890